Skip to main content
Back
Watch Compare

Envoy Medical, Inc.

Data quality: 100%
Also listed as COCHW NASDAQ
COCH
NASDAQ Manufacturing Measuring & Analyzing Instruments
$0.62
▲ $0.01 (0.82%)
Mkt Cap: 49.20 M
Price
$0.64
Mkt Cap
49.20 M
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—

Quick Summary

Key Takeaways

Negative free cash flow of -18.38 M
Capital intensive — 74.27% of revenue goes to capex

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)7.11%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
N/A
ROIC-3219.27%
Net Margin-9857.26%
Op. Margin-9240.66%

Safety

Debt / Equity
N/A
Current Ratio0.64
Interest Coverage-14.01

Valuation

PE (TTM)
-2.07
Below sector avg (-1.49)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1385 peers)
Metric Stock Sector Median
P/E -2.1 -1.5
P/B — 1.6
ROE % — -54.0
Net Margin % -9857.3 -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

Analyst Price Target

1 analyst
Buy
Current
$0.62
+305.2%
Target
$2.50
$2.50
$2.50
$2.50
Forecast
Forward EPS -$0.30
Est. Revenue 0.0

Earnings Estimates

Period EPS Est. Revenue Est. Analysts
FY2027 — 0.0 —
FY2026 -$0.30
-$0.30 – -$0.30
 240,000.0 1

Earnings Surprises

Last 3 quarters
Quarter Est. EPS Actual EPS Surprise
Q32025 -$0.29 -$0.35 -22.1%
Q22025 -$0.29 -$0.32 -9.1%
Q12025 -$0.36 -$0.29 +18.9%

All Fundamental Metrics
Growth
Revenue Growth (1Y) 7.11% Revenue Growth (3Y) -12.67%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 241,000.0 Net Income (TTM) -23.76 M
ROE N/A ROA -262.77%
Gross Margin N/A Operating Margin -9240.66%
Net Margin -9857.26% Free Cash Flow (TTM) -18.38 M
ROIC -3219.27% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0.64
Interest Coverage -14.01 Asset Turnover 0.03
Working Capital -3.23 M Tangible Book Value -7.66 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -2.07 Forward P/E N/A
P/B Ratio N/A P/S Ratio 204.17
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -37.35%
Market Cap 49.20 M Enterprise Value 49.20 M
Per Share
EPS (Diluted TTM) -1.23 Revenue / Share 0.00
FCF / Share -0.24 OCF / Share -0.24
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 74.27% FCF Conversion 77.37%
SBC-Adj. FCF -19.00 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 241,000.0 225,000.0 316,000.0 — —
Net Income -23.76 M -20.80 M -29.91 M 19.23 M -251,633.0
EPS (Diluted) -1.23 -1.49 -2.38 — —
Gross Profit — — — — —
Operating Income -22.27 M -19.26 M -18.37 M -4.89 M -5.20 M
EBITDA — — — — —
R&D Expenses 12.49 M 10.18 M 8.96 M — —
SG&A Expenses — — 7.28 M — —
D&A — — — — —
Interest Expense 1.59 M 816,000.0 — — —
Income Tax — — — 1.50 M —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 8.56 M 11.54 M 7.64 M 430.62 M 426.90 M
Total Liabilities 20.33 M 30.38 M 9.40 M 18.79 M 38.62 M
Shareholders' Equity -12.16 M -18.84 M -1.76 M -17.91 M -36.71 M
Total Debt — — — — —
Cash & Equivalents — — 4.22 M 107,773.0 149,845.0
Current Assets 6.28 M 9.38 M 6.83 M 220,422.0 863,167.0
Current Liabilities 11.56 M 7.54 M 6.64 M 7.31 M 2.68 M